{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:31:53Z","timestamp":1787761913095,"version":"build-2784847793"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Infectious keratitis remains a leading cause of corneal blindness worldwide. The role of topical anti-inflammatory agents such as corticosteroids, calcineurin inhibitors, and other steroid-sparing therapies in the management of infectious keratitis has not been clearly defined and remains controversial. The benefit of corticosteroids in the treatment of infectious keratitis varies depending on the causal organism. While one large randomized-controlled trial supports their use in some cases of bacterial keratitis, high-quality evidence for their use in fungal or amoebic keratitis is not well-established. There are few case reports and no randomized control trials evaluating the safety and efficacy of steroids in the treatment of fungal or amoebic keratitis, although generally steroids are avoided in fungal keratitis and used judiciously in amoebic keratitis. Topical steroid-sparing anti-inflammatory treatments such as calcineurin inhibitors may especially have a role in the treatment of fungal keratitis, where topical corticosteroid use is generally avoided. Emerging adjunctive therapies, including amniotic membrane transplantation, photoactivated chromophore cross-linking, and experimental immunomodulators, show preclinical or early clinical promise but lack robust human data. Large, multicenter trials are needed to establish evidence-based protocols for infectious keratitis treatment that balance infection eradication with control of host inflammation. While judicious anti-inflammatory use appears beneficial in many cases, optimal timing, dosing, and combination strategies remain uncertain. This review summarizes current evidence on topical anti-inflammatory therapy for infectious keratitis, focusing on bacterial, fungal and amoebic infections, and highlights key gaps in knowledge.<\/jats:p>","DOI":"10.4103\/sjopt.sjopt_28_26","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:18:06Z","timestamp":1781018286000},"page":"139-144","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Anti-inflammatory treatments in microbial keratitis"],"prefix":"10.4103","volume":"40","author":[{"given":"Esteban","family":"Peralta","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kourtney","family":"Houser","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Duke University School of Medicine, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.survophthal.2018.12.003","article-title":"The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance","volume":"64","author":"Ung","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s40135-013-0026-0","article-title":"Topical corticosteroids in the management of bacterial keratitis","volume":"1","author":"Tuli","year":"2013","journal-title":"Current ophthalmology reports."},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-0420.2004.00229.x","article-title":"Efficacy of early systemic betamethasone or cyclosporin A after corneal alkali injury via inflammatory cytokine reduction","volume":"82","author":"Den","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"R4-20260610","first-page":"2665","article-title":"Combined treatment with antioxidants and immunosuppressants on cytokine release by human peripheral blood mononuclear cells \u2013Chemically injured keratocyte reaction","volume":"17","author":"Yi","year":"2011","journal-title":"Mol Vis"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-4835(87)80003-9","article-title":"The influence of topical corticosteroid therapy upon polymorphonuclear leukocyte distribution, vascular integrity and ascorbate levels in endotoxin-induced inflammation of the rabbit eye","volume":"44","author":"Williams","year":"1987","journal-title":"Exp Eye Res"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1034\/j.1600-0420.1999.770203.x","article-title":"Influence of topical treatment on epithelial wound healing and pain in the early postoperative period following photorefractive keratectomy","volume":"77","author":"Tomas-Barberan","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"R7-20260610","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/bjo.2008.151167","article-title":"Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: The Portsmouth corneal ulcer study","volume":"93","author":"Ibrahim","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R8-20260610","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archophthalmol.2010.144","article-title":"Epidemiology of ulcerative keratitis in Northern California","volume":"128","author":"Jeng","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/ICU.0000000000000273","article-title":"Use of adjunctive topical corticosteroids in bacterial keratitis","volume":"27","author":"Ni","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"key":"R10-20260610","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archopht.1985.01050020122034","article-title":"Polymorphonuclear leukocyte kinetics in experimentally induced keratitis","volume":"103","author":"Chusid","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archophthalmol.2008.504","article-title":"Rationale for adjunctive topical corticosteroids in bacterial keratitis","volume":"127","author":"Hindman","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1542-0124(12)70128-3","article-title":"Growth factor, cytokine and protease interactions during corneal wound healing","volume":"1","author":"Lim","year":"2003","journal-title":"Ocul Surf"},{"key":"R13-20260610","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3129\/i10-054","article-title":"Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: Double-blinded randomized clinical trial","volume":"46","author":"Blair","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/bjo.2008.147298","article-title":"Corticosteroids for bacterial corneal ulcers","volume":"93","author":"Srinivasan","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archophthalmol.2011.315","article-title":"Corticosteroids for bacterial keratitis: The steroids for corneal ulcers trial (SCUT)","volume":"130","author":"Srinivasan","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ajo.2012.06.001","article-title":"Nocardia keratitis: Clinical course and effect of corticosteroids","volume":"154","author":"Lalitha","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2013.09.025","article-title":"The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial","volume":"157","author":"Srinivasan","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R18-20260610","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bjophthalmol-2015-307955","article-title":"Corticosteroids as a therapy for bacterial keratitis: An evidence-based review of 'who, when and why'","volume":"100","author":"Tallab","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jamaophthalmol.2013.778","article-title":"Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis","volume":"131","author":"Borkar","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R20-20260610","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2012.06.030","article-title":"Infectious keratitis progressing to endophthalmitis: A 15-year study of microbiology, associated factors, and clinical outcomes","volume":"119","author":"Henry","year":"2012","journal-title":"Ophthalmology"},{"key":"R21-20260610","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/ICO.0000000000001794","article-title":"High-dose steroid treatment of bacterial keratitis","volume":"38","author":"Green","year":"2019","journal-title":"Cornea"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1542-0124(12)70291-4","article-title":"Contribution of in vivo confocal microscopy to the diagnosis and management of infectious keratitis","volume":"7","author":"Labb\u00e9","year":"2009","journal-title":"Ocul Surf"},{"key":"R23-20260610","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/ICO.0000000000000804","article-title":"Update on acanthamoeba keratitis: Diagnosis, treatment, and outcomes","volume":"35","author":"Maycock","year":"2016","journal-title":"Cornea"},{"key":"R24-20260610","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.pt.2022.08.007","article-title":"Acanthamoeba, an environmental phagocyte enhancing survival and transmission of human pathogens","volume":"38","author":"Rayamajhee","year":"2022","journal-title":"Trends Parasitol"},{"key":"R25-20260610","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/ICO.0000000000003340","article-title":"Steroids in the management of infectious keratitis","volume":"42","author":"Keenan","year":"2023","journal-title":"Cornea"},{"key":"R26-20260610","first-page":"2885","article-title":"Effect of steroids on acanthamoeba cysts and trophozoites","volume":"42","author":"McClellan","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R27-20260610","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.ophtha.2014.01.031","article-title":"The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis","volume":"121","author":"Robaei","year":"2014","journal-title":"Ophthalmology"},{"key":"R28-20260610","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ophtha.2016.01.020","article-title":"The impact of topical corticosteroids used in conjunction with antiamoebic therapy on the outcome of Acanthamoeba keratitis","volume":"123","author":"Carnt","year":"2016","journal-title":"Ophthalmology"},{"key":"R29-20260610","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.ophtha.2008.04.038","article-title":"Prognostic factors affecting visual outcome in Acanthamoeba keratitis","volume":"115","author":"Tu","year":"2008","journal-title":"Ophthalmology"},{"key":"R30-20260610","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00003226-199705000-00004","article-title":"The role of topical corticosteroids in the management of Acanthamoeba keratitis","volume":"16","author":"Park","year":"1997","journal-title":"Cornea"},{"key":"R31-20260610","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.ophtha.2014.06.033","article-title":"Acanthamoeba sclerokeratitis: Epidemiology, clinical features, and treatment outcomes","volume":"121","author":"Iovieno","year":"2014","journal-title":"Ophthalmology"},{"key":"R32-20260610","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajo.2020.09.048","article-title":"Oral miltefosine as salvage therapy for refractory Acanthamoeba keratitis","volume":"223","author":"Thulasi","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R33-20260610","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/ICO.0000000000002827","article-title":"Use of topical cyclosporine 0.1% in therapeutic penetrating keratoplasty for fungal keratitis","volume":"41","author":"Chatterjee","year":"2022","journal-title":"Cornea"},{"key":"R34-20260610","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.4103\/ijo.IJO_1952_18","article-title":"Outcomes of therapeutic penetrating keratoplasty in 198 eyes with fungal keratitis","volume":"67","author":"Mundra","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"R35-20260610","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.survophthal.2021.08.002","article-title":"Fungal keratitis: Mechanisms of infection and management strategies","volume":"67","author":"Donovan","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"R36-20260610","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/0301-4738.185592","article-title":"Recent advances in diagnosis and management of mycotic keratitis","volume":"64","author":"Maharana","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"R37-20260610","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/OPTH.S447138","article-title":"Fungal keratitis: Diagnosis, management, and recent advances","volume":"18","author":"Awad","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"R38-20260610","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/bjo.85.9.1070","article-title":"Treatment of fungal keratitis by penetrating keratoplasty","volume":"85","author":"Xie","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R39-20260610","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jtos.2021.12.001","article-title":"Fungal keratitis: A review of clinical presentations, treatment strategies and outcomes","volume":"24","author":"Sharma","year":"2022","journal-title":"Ocul Surf"},{"key":"R40-20260610","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00003226-200203000-00006","article-title":"Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis","volume":"21","author":"Perry","year":"2002","journal-title":"Cornea"},{"key":"R41-20260610","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/jcm10061178","article-title":"Topical corticosteroids and fungal keratitis: A review of the literature and case series","volume":"10","author":"Knutsson","year":"2021","journal-title":"J Clin Med"},{"key":"R42-20260610","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.icl.0000249595.27520.2e","article-title":"Fungal keratitis: Emerging trends and treatment outcomes","volume":"32","author":"Iyer","year":"2006","journal-title":"Eye Contact Lens"},{"key":"R43-20260610","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archopht.1971.01000010416010","article-title":"Deep fungal corneal abscess. Combined corticosteroid therapy","volume":"86","author":"O'Day","year":"1971","journal-title":"Arch Ophthalmol"},{"key":"R44-20260610","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/ICO.0000000000003934","article-title":"Adjunctive topical calcineurin inhibitors during the treatment of fungal keratitis: Practice patterns and opinions","volume":"44","author":"Christy","year":"2025","journal-title":"Cornea"},{"key":"R45-20260610","first-page":"1","volume":"8","author":"Peralta","year":"2025","journal-title":"Cyclosporine as postoperative immunomodulating agent in penetrating keratoplasty for keratomycosis introduc on"},{"key":"R46-20260610","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ICO.0000000000000291","article-title":"Topical cyclosporine in corneal transplantation","volume":"34","author":"Ziaei","year":"2015","journal-title":"Cornea"},{"key":"R47-20260610","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1721727X17740305","article-title":"The effects of FK506 combined with natamycin in the treatment of experimental fungal keratitis by suppressing NLRP3 inflammasome activation","volume":"15","author":"Liang","year":"2017","journal-title":"Eur J Inflamm"},{"key":"R48-20260610","first-page":"187","article-title":"Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis","volume":"24","author":"Zhong","year":"2018","journal-title":"Mol Vis"},{"key":"R49-20260610","doi-asserted-by":"crossref","first-page":"864912","DOI":"10.3389\/fcimb.2022.864912","article-title":"The synergistic effect of tacrolimus (FK506) or everolimus and azoles against scedosporium and lomentospora species in vivo and in vitro","volume":"12","author":"Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R50-20260610","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2147\/OPTH.S23201","article-title":"Clinical course and management of postoperative methicillin-resistant Staphylococcus aureus keratitis in immunocompromised patients: Two case reports","volume":"5","author":"Chou","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"R51-20260610","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/cells9071713","article-title":"Experimental models for fungal keratitis: An overview of principles and protocols","volume":"9","author":"Montgomery","year":"2020","journal-title":"Cells"},{"key":"R52-20260610","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.ico.0000227885.19124.6f","article-title":"Amniotic membrane transplantation for persistent corneal ulcers and perforations in acute fungal keratitis","volume":"25","author":"Chen","year":"2006","journal-title":"Cornea"},{"key":"R53-20260610","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.ico.0000151547.08113.d1","article-title":"Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: A review of 33 cases","volume":"24","author":"Hick","year":"2005","journal-title":"Cornea"},{"key":"R54-20260610","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40662-021-00272-0","article-title":"PACK-CXL versus antimicrobial therapy for bacterial, fungal, and mixed infectious keratitis: A prospective randomized phase 3 trial","volume":"9","author":"Hafezi","year":"2022","journal-title":"Eye Vis (Lond)"},{"key":"R55-20260610","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12886-025-04038-3","article-title":"Corneal cross-linking for infectious keratitis of various causes: An umbrella review","volume":"25","author":"Farhadi","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"R56-20260610","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jtos.2019.08.006","article-title":"Photoactivated chromophore for infectious keratitis \u2013Corneal cross-linking (PACK-CXL): A systematic review and meta-analysis","volume":"17","author":"Ting","year":"2019","journal-title":"Ocul Surf"},{"key":"R57-20260610","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ophtha.2019.08.029","article-title":"Cross-linking-assisted infection reduction: A randomized clinical trial evaluating the effect of adjuvant cross-linking on outcomes in fungal keratitis","volume":"127","author":"Prajna","year":"2020","journal-title":"Ophthalmology"},{"key":"R58-20260610","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13643-023-02380-5","article-title":"Photoactivated chromophore-corneal cross-linking accelerates corneal healing in fungal keratitis: An updated meta-analysis","volume":"12","author":"Liu","year":"2023","journal-title":"Syst Rev"},{"key":"R59-20260610","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12886-019-1235-6","article-title":"MSCs helped reduce scarring in the cornea after fungal infection when combined with anti-fungal treatment","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"R60-20260610","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.007","article-title":"The therapeutic potential of chondroitin sulfate in Aspergillus fumigatus keratitis","volume":"147","author":"Luan","year":"2022","journal-title":"Mol Immunol"},{"key":"R61-20260610","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40662-020-00217-z","article-title":"The anti-scarring effect of corneal stromal stem cell therapy is mediated by transforming growth factor ?3","volume":"7","author":"Weng","year":"2020","journal-title":"Eye Vis (Lond)"},{"key":"R62-20260610","doi-asserted-by":"crossref","first-page":"175607","DOI":"10.1016\/j.ejphar.2023.175607","article-title":"Pentoxifylline treats Aspergillus fumigatus keratitis by reducing fungal burden and suppressing corneal inflammation","volume":"945","author":"Chi","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"R63-20260610","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00417-016-3412-0","article-title":"Therapeutic dilemma in fungal keratitis: Administration of steroids for immune rejection early after keratoplasty","volume":"254","author":"Wang","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R64-20260610","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12886-024-03506-6","article-title":"Topical tacrolimus for high-risk corneal transplantation: A randomized, clinical trial","volume":"24","author":"Shimazaki","year":"2024","journal-title":"BMC Ophthalmol"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_28_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:10:29Z","timestamp":1787760629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_28_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/sjopt.sjopt_28_26","relation":{},"ISSN":["1319-4534","2542-6680"],"issn-type":[{"value":"1319-4534","type":"print"},{"value":"2542-6680","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2026-01-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}